Abstract
Mabinlin II is a thermostable sweet protein isolated from the mature seeds of Capparis masaikai Levl. grown in the subtropical region of the South of China. The Mabinlin II has been crystallized and diffraction data were collected to 1.7 Å resolution. The crystal belongs to space group C2 with unit cell parameters a = 80.11 Å, β = 51.08 Å, c = 47.34 Å, b = 122.77° .
Keywords: Sweet protein, Mabinlin II, Heat-stable protein, Capparis masaikai Levl., crystallization
Protein & Peptide Letters
Title: Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II
Volume: 13 Issue: 3
Author(s): De-Feng Li, De-Yu Zhu, Zhong Hu and Da-Cheng Wang
Affiliation:
Keywords: Sweet protein, Mabinlin II, Heat-stable protein, Capparis masaikai Levl., crystallization
Abstract: Mabinlin II is a thermostable sweet protein isolated from the mature seeds of Capparis masaikai Levl. grown in the subtropical region of the South of China. The Mabinlin II has been crystallized and diffraction data were collected to 1.7 Å resolution. The crystal belongs to space group C2 with unit cell parameters a = 80.11 Å, β = 51.08 Å, c = 47.34 Å, b = 122.77° .
Export Options
About this article
Cite this article as:
Li De-Feng, Zhu De-Yu, Hu Zhong and Wang Da-Cheng, Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II, Protein & Peptide Letters 2006; 13 (3) . https://dx.doi.org/10.2174/092986606775338443
DOI https://dx.doi.org/10.2174/092986606775338443 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vasopressin and Oxytocin in Control of the Cardiovascular System
Current Neuropharmacology Application of Pharmacogenomics to Dietary Cancer Chemoprevention
Current Pharmacogenomics A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Current Pharmaceutical Design Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Current Pharmaceutical Biotechnology Potential of Taming MicroRNA on Driver Seat to Control Mitochondrial Horses in Breast Carcinoma
MicroRNA Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation
Current Stem Cell Research & Therapy An Efficient Synthesis of 4-Aryl-1,4-dihydropyridines Via VB1 Catalyzed Hantzsch Reaction
Letters in Organic Chemistry Recent Advances in Pulmonary Hypertension Therapy
Recent Patents on Cardiovascular Drug Discovery Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design Cardiovascular Disease and Inflammation: Novel Biomarkers of Inflammation and Endothelial Activation
Vascular Disease Prevention (Discontinued) No Association Between GRM3 and Japanese Methamphetamine- Induced Psychosis
Current Neuropharmacology Muscle Metabolism and Exercise Capacity in Cachexia
Current Pharmaceutical Design Bacterial Adaptation and Infection
Inflammation & Allergy - Drug Targets (Discontinued) Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Roles of SUMOylation in Heart Development and Cardiovascular Diseases
Current Molecular Medicine The Future of Collateral Artery Research
Current Cardiology Reviews “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy A Quantitative Structure-Activity Relationship Study on a Novel Series of Hydroxamic Acid Analogs Acting as Matrix Metalloproteinase Inhibitors
Letters in Drug Design & Discovery